BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 125 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,940,805 | +1.8% | 415,368 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $2,888,991 | -13.9% | 410,368 | +2.0% | 0.00% | 0.0% |
| Q1 2023 | $3,355,749 | -34.9% | 402,368 | -10.4% | 0.00% | -50.0% |
| Q4 2022 | $5,154,153 | -7.1% | 448,968 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $5,546,000 | +20.5% | 440,168 | +1.2% | 0.00% | +33.3% |
| Q2 2022 | $4,602,000 | -33.5% | 434,968 | +2.2% | 0.00% | -25.0% |
| Q1 2022 | $6,918,000 | +27.2% | 425,468 | +8.4% | 0.00% | +33.3% |
| Q4 2021 | $5,437,000 | -3.6% | 392,568 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $5,641,000 | -8.5% | 392,568 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $6,164,000 | +50.2% | 389,868 | -3.4% | 0.00% | +33.3% |
| Q1 2021 | $4,103,000 | +38.0% | 403,468 | +1.1% | 0.00% | +50.0% |
| Q4 2020 | $2,974,000 | +120.8% | 399,168 | +1.8% | 0.00% | +100.0% |
| Q3 2020 | $1,347,000 | -26.7% | 392,268 | +1.7% | 0.00% | -50.0% |
| Q2 2020 | $1,838,000 | +207.4% | 385,668 | +29.1% | 0.00% | +100.0% |
| Q1 2020 | $598,000 | -39.0% | 298,800 | +5.2% | 0.00% | 0.0% |
| Q4 2019 | $980,000 | +144.4% | 284,000 | +103.0% | 0.00% | – |
| Q3 2019 | $401,000 | -24.3% | 139,900 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $530,000 | -53.5% | 139,900 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,139,000 | +4.2% | 139,900 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $1,093,000 | +19.3% | 135,400 | +12.8% | 0.00% | 0.0% |
| Q3 2018 | $916,000 | +33.1% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $688,000 | -15.8% | 120,000 | -29.9% | 0.00% | 0.0% |
| Q1 2018 | $817,000 | -2.9% | 171,300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $841,000 | -6.3% | 171,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $898,000 | +41.2% | 171,300 | +49.9% | 0.00% | 0.0% |
| Q2 2017 | $636,000 | -33.8% | 114,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $960,000 | +57.4% | 114,300 | +18.7% | 0.00% | 0.0% |
| Q4 2016 | $610,000 | +43.5% | 96,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $425,000 | +55.7% | 96,300 | 0.0% | 0.00% | – |
| Q2 2016 | $273,000 | +3.8% | 96,300 | 0.0% | 0.00% | – |
| Q1 2016 | $263,000 | -67.5% | 96,300 | +22.8% | 0.00% | -100.0% |
| Q4 2015 | $809,000 | -9.5% | 78,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $894,000 | -12.2% | 78,400 | +15.0% | 0.00% | -33.3% |
| Q2 2015 | $1,018,000 | +69.9% | 68,200 | +2.9% | 0.00% | +50.0% |
| Q1 2015 | $599,000 | -25.7% | 66,300 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $806,000 | +29.0% | 66,300 | +3.8% | 0.00% | +50.0% |
| Q3 2014 | $625,000 | -34.5% | 63,900 | -14.6% | 0.00% | -50.0% |
| Q2 2014 | $954,000 | +63.4% | 74,800 | +35.5% | 0.00% | +100.0% |
| Q1 2014 | $584,000 | +75.4% | 55,200 | +26.0% | 0.00% | +100.0% |
| Q4 2013 | $333,000 | – | 43,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |